#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	10586	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2159	485.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	560	C	550	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19966	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3541	560.6	0	.	n	.	0	T695C	SNP	695	695	T	1027	1027	C	629	C,T,A	598,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19966	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3541	560.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1669	1669	A	635	A	626	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19966	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3541	560.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2303	2303	C	605	C,T	584,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19966	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3541	560.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2377	2377	A	623	A	613	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19966	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3541	560.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2929	2929	C	601	C,T	586,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	20	blaTEM	861	141	100.0	blaTEM.l15.c30.ctg.1	316	2.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	20	blaTEM	861	268	100.0	blaTEM.l15.c30.ctg.2	268	2.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	V36A	NONSYN	106	108	GTG	513	515	GCG	129;128;127	G;C;G	122;124;123	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	555	557	CGG	113;113;112	C;G;G	111;109;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	S68L	NONSYN	202	204	TCG	609	611	TTG	110;109;109	T,G;T;G	98,1;107;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	A90V	NONSYN	268	270	GCG	675	677	GTT	117;114;114	G;T;T,A	111;108;107,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	I105V	NONSYN	313	315	ATT	720	722	GTT	113;112;114	G;T,G;T	109;102,1;110	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	N125T	NONSYN	373	375	AAT	780	782	ACC	117;117;114	A;C;C	113;117;113	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	R135C	NONSYN	403	405	CGT	810	812	TGT	120;120;118	T;G;T	104;116;109	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	K151E	NONSYN	451	453	AAA	858	860	GAA	106;106;107	G;A;A	99;101;103	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	T152N	NONSYN	454	456	ACC	861	863	AAC	107;106;111	A,T;A;C	102,1;102;107	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	A172T	NONSYN	514	516	GCG	921	923	ACA	99;99;101	A;C;A	98;98;98	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	A175E	NONSYN	523	525	GCG	930	932	GAA	103;106;106	G;A;A	99;104;103	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	E176T	NONSYN	526	528	GAA	933	935	ACC	107;109;107	A;C;C	101;107;103	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	I178V	NONSYN	532	534	ATC	939	941	GTC	107;107;104	G;T;C	104;101;101	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	I188T	NONSYN	562	564	ATA	969	971	ACG	101;99;97	A;C;G	98;97;95	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1005	1007	AAC	93;93;94	A;A;C	93;93;93	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1065	1067	TTG	102;102;100	T;T;G	99;99;94	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1122	1124	ACC	90;92;93	A;C;C	83;84;86	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1125	1127	GAC	94;93;92	G;A;C	88;84;87	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1134	1136	GCG	93;88;88	G;C;G	90;72;86	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1170	1172	GCT	69;70;71	G;C;T	69;67;63	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1102	folP	858	858	91.61	folP.l15.c17.ctg.1	1570	69.8	1	SNP	p	R230S	1	.	.	688	690	AGC	1095	1097	AGC	113;113;112	A;G;C	107;110;108	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4088	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3467	117.3	1	SNP	p	S91F	0	.	.	271	273	TCC	651	653	TCC	139;139;140	T;C;C	135;138;136	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4088	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3467	117.3	1	SNP	p	D95G	0	.	.	283	285	GAC	663	665	GAC	134;133;133	G;A;C	131;130;130	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4088	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3467	117.3	1	SNP	p	D95N	0	.	.	283	285	GAC	663	665	GAC	134;133;133	G;A;C	131;130;130	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1166	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1232	93.5	1	SNP	p	G45D	1	.	.	133	135	GAC	473	475	GAC	137;136;136	G;A;C,A	135;135;132,1	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	726	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1077	66.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3654	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3201	113.5	1	SNP	p	D86N	0	.	.	256	258	GAC	712	714	GAC	156;155;152	G;A;C	152;148;151	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3654	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3201	113.5	1	SNP	p	S87I	0	.	.	259	261	AGT	715	717	AGT	152;153;156	A;G;T	150;151;150	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3654	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3201	113.5	1	SNP	p	S87R	0	.	.	259	261	AGT	715	717	AGT	152;153;156	A;G;T	150;151;150	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3654	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3201	113.5	1	SNP	p	S87W	0	.	.	259	261	AGT	715	717	AGT	152;153;156	A;G;T	150;151;150	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3654	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3201	113.5	1	SNP	p	S88P	0	.	.	262	264	TCC	718	720	TCC	156;158;158	T,C;C;C	150,1;155;155	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2930	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2875	101.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1643	1645	GGC	145;144;144	G;G;C	142;140;141	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1267	1269	GCC	168;166;165	G,T;C;C	165,2;166;164	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1270	1272	ATG	166;166;164	A;T;G	165;164;163	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1282	1284	ACC	161;162;162	A;C;C	152;160;158	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1282	1284	ACC	161;162;162	A;C;C	152;160;158	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1783	1785	ACC	137;137;139	A;C;C	133;133;136	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1837	1839	GCG	128;128;129	G;C;G	126;125;126	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1837	1839	GCG	128;128;129	G;C;G	126;125;126	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1960	1962	GGT	106;104;103	G;G;T	100;96;96	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1969	1971	AGC	92;92;91	A;G;C	88;87;87	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2954	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2316	126.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1987	1989	CCG	79;76;75	C,G,A;C;G	68,1,1;67;63	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4114	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3013	135.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1824	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1826	99.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	118	C	113	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1962	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1577	122.9	0	.	p	.	0	E41K	NONSYN	121	123	GAA	403	405	AAA	144;144;149	A;A;A	140;143;146	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1962	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1577	122.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	913	913	T	156	T,A	145,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1962	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1577	122.9	1	SNP	p	G120K	0	.	.	358	360	GGT	640	642	GGT	150;149;150	G;G;T	147;145;139	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1962	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1577	122.9	1	SNP	p	A121D	0	.	.	361	363	GCC	643	645	GCC	149;147;147	G;C;C	144;142;144	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1962	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1577	122.9	1	SNP	p	A121N	0	.	.	361	363	GCC	643	645	GCC	149;147;147	G;C;C	144;142;144	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	7148	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5088	139.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2064	2066	CAT	165;166;166	C;A;T	156;158;158	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	804	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	973	81.0	1	SNP	p	V57M	1	.	.	169	171	ATG	464	466	ATG	160;159;161	A;T;G	158;158;158	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
